A randomised phase II study comparing Capecitabine with Capecitabine and oral
Cyclophosphamide in patients with advanced breast cancer.
Protocol CTNZ 01-03
Registration number:
|
ISRCTN68662102 & ACTRN12605000377639 |
Ethics number:
|
AKY/04/02/001 |
This trial is a phase II study which is comparing two chemotherapy treatments for
advanced breast cancer - capecitabine and capecitabine with cyclophosphamide. Both
drugs being used are taken by mouth, and are both already used to treat breast cancer,
but they are not usually used together.
Progress
Auckland, Waikato, Palmerston North, Wellington, Nelson, Christchurch, Dunedin and
Southland sites recruited patients into this study. The trial has reached its recruitment
target and now has ceased accrual.
There were 82 participants taking part in the trial (as of 2 March 2007):
- Auckland 38
- Waikato 13
- Wellington 10
- Christchurch 7
- Dunedin 5
- Palmerston North 9
Results
CycloxII ASCO 2008 Poster(165.2KB PDF)
Centres involved
- Auckland (lead centre)
- Waikato
- Palmerston North
- Wellington
- Nelson
- Christchurch
- Dunedin & Southland
